ARK-1 (35C1) Antibody sc-56881 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemARK-1 (35C1) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-56881
Antibody TypePrimary Antibodies
NCBI Gene AliasesStk6, IAK, Ark1, BTAK, STK15, Aurora-A, AURA, AIK, STK7, Ayk1, AIRK1, IAK1, ARK-1, STK6, ARK1, PPP1R47
Quantity200 µg/ml
Clone35C1
ApplicationsWB, IP, IF, ELISA
Reactivitymouse, rat, human
Conjugate/TagUnconjugated
Hostmouse
FormatPurified
ClonalityMonoclonal
NCBI Full Gene Nameaurora kinase A
TargetARK-1
IsotypeIgG2b

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) DHX33 inhibitors induced transcriptional changes for a subset of genes in cancer cellsScientific ReportsJune 5, 2026Xingshun Wang, Yichu Fu, Xiyu Tang, Yandong Zhang(A300-800A); anti-DHX33, Santa Cruz Biotechnology (B-4, sc-390573); anti-Aurora A, Santa Cruz Biotechnology (sc-56881); anti-MCM2, Santa Cruz Biotechnology (sc-9839); anti-MCM3, Santa Cruz Biotechnology (sc-9850); anti-MCM4,

(2) KRAS mutated lung adenocarcinoma responds to pan-ERBB and Aurora kinase inhibitorsnpj Precision OncologyJanuary 12, 2026Iris Z. Uras, Marija V. Trkulja, Abdelrahman K.A.A. Salama, Jaqueline Horvath, Khushi Asnani, Christoph Trenk, Stefan Kubicek, Martin Bilban, Herwig P. Moll, Emilio Casanovaphospho-Aurora A /Aurora B/ Aurora C (T288 /T232 /T198, Cell Signaling #2914), Aurora A (Santa Cruz sc-56881), Aurora B (Cell Signaling #3094), phospho-STAT3 (Y705, Cell Signaling #9131), STAT3 (Cell Signaling

(3) Cross-Reactivity of N6AMT1 Antibodies with Aurora Kinase A: An Example of Antibody-Specific Non-SpecificityAntibodies (Basel, Switzerland)April 22, 2024Brūmele B, Serova E, Lupp A, Suija M, Mutso M, Kurg R.anti-GAPDH (1:10,000, sc-32233, Santa Cruz Biotechnology, Dallas, TX, USA), anti-Aurora kinase A (1:500, sc-56881, Santa Cruz Biotechnology, Dallas, TX, USA), and anti-EGFP (1:10,000, Institute of Technology; University

(4) Aurora A polyubiquitinates the BRCA1-interacting protein OLA1 to promote centrosome maturationCell reportsAugust 29, 2023Fang Z, Li X, Yoshino Y, Suzuki M, Qi H, Murooka H, Katakai R, Shirota M, Mai Pham TA, Matsuzawa A, et al.

(5) Iron deficiency in hepatocellular carcinoma cells induced sorafenib resistance by upregulating HIF-1α to inhibit apoptosisBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapieJuly 1, 2023Gao Z, Wang D, Yang J, Li M, Ling C, Lv D, Cao Y, Chen Z, Shi C, Shen H, et al.

(6) Phospholipase D1 promotes astrocytic differentiation through the FAK/AURKA/STAT3 signaling pathway in hippocampal neural stem/progenitor cellsBiochimica et biophysica acta. Molecular cell researchDecember 1, 2022Kang MJ, Jin N, Park SY, Han JS.

(7) HNRNPA2B1 as a trigger of RNA switch modulates the miRNA-mediated regulation of CDK6iScienceNovember 19, 2021Yin M, Cheng M, Liu C, Wu K, Xiong W, Fang J, Li Y, Zhang B.sc-47778; RRID:AB_626632 anti-VHL,Santa Cruz,Cat# sc-135657; AB_2215955 anti-AURKA,Santa Cruz,Cat# sc-56881; RRID:AB_667838 anti-RELA(p65),Santa Cruz,Cat# sc-8008; RRID:AB_628017 anti-HNRNPL,Santa Cruz,Cat#

(8) FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targetedJournal of hepatologyAugust 1, 2021Vallejo A, Erice O, Entrialgo-Cadierno R, Feliu I, Guruceaga E, Perugorria MJ, Olaizola P, Muggli A, Macaya I, O'Dell M, et al.

(9) Targeting RNA helicase DHX33 blocks Ras-driven lung tumorigenesis in vivoCancer scienceOctober 1, 2020Wang X, Feng W, Peng C, Chen S, Ji H, Zhong H, Ge W, Zhang Y.antibodies were sourced as follows: anti‐GAPDH, Absin (abs830030); anti‐Aurora A, Santa Cruz Biotechnology (sc‐56881); anti‐MCM2, Santa Cruz Biotechnology (sc‐9839); anti‐MCM3, Santa Cruz Biotechnology (sc‐9850); anti‐MCM4,

(10) Inhibitor of Differentiation-1 Sustains Mutant KRAS-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 NetworkCancer researchFebruary 1, 2019Román M, López I, Guruceaga E, Baraibar I, Ecay M, Collantes M, Nadal E, Vallejo A, Cadenas S, Miguel ME, et al.

(11) Modulated self-reversed magnetic hysteresis in iron oxidesScientific reportsFebruary 21, 2017Ma J, Chen K.

(12) An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancerNature communicationsFebruary 21, 2017Vallejo A, Perurena N, Guruceaga E, Mazur PK, Martinez-Canarias S, Zandueta C, Valencia K, Arricibita A, Gwinn D, Sayles LC, et al.CST), FOSL1 (1:500, sc-376148, Santa Cruz Biotechnology (SCB)), KRAS (1:500, sc-30, SCB), AURKA (1:500, sc-56881, SCB), CCNB1 (1:500, sc-245, SCB), FOXM1 (1:500, sc-376471, CST), HURP (1:500, sc-377004, SCB), KIF20A

(13) WWOX modulates the gene expression profile in the T98G glioblastoma cell line rendering its phenotype less malignantOncology reportsOctober 1, 2014Kośla K, Nowakowska M, Pospiech K, Bednarek AK.antibodies used were goat polyclonal anti-WWOX (cat. no. sc-20529), mouse monoclonal anti-ARK1 (cat. no. sc-56881), goat polyclonal anti-KLF8 (cat. no. sc-69294), rabbit polyclonal anti-JAK1 (cat. no. sc-277) (all

Be the First to Write a Review!

ARK-1 (35C1) Antibody

ARK-1 (35C1) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (13)

Reviews

ARK-1 (35C1) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map